INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 50,900 Value ($000) $204 Avg Close Range
Q3 2023
Shares 135,783 Value ($000) $570 Avg Close Range
Q2 2023
Shares 127,907 Value ($000) $712 Avg Close Range
Q1 2023
Shares 195,097 Value ($000) $1,118 Avg Close Range
Q4 2021
Shares 36,033 Value ($000) $247 Avg Close Range
Q3 2021
Shares 33,408 Value ($000) $387 Avg Close Range
Q2 2021
Shares 40,202 Value ($000) $685 Avg Close Range
Q1 2021
Shares 51,813 Value ($000) $1,026 Avg Close Range
Q3 2020
Shares 12,418 Value ($000) $326 Avg Close Range